In  ||| S:0 E:3 ||| IN
vitro  ||| S:3 E:9 ||| JJ
transdifferentiation  ||| S:9 E:30 ||| NN
of  ||| S:30 E:33 ||| IN
human  ||| S:33 E:39 ||| JJ
cultured  ||| S:39 E:48 ||| NNS
CD34+  ||| S:48 E:54 ||| RB
stem  ||| S:54 E:59 ||| VB
cells  ||| S:59 E:65 ||| NNS
into  ||| S:65 E:70 ||| IN
oligodendrocyte  ||| S:70 E:86 ||| JJ
precursors  ||| S:86 E:97 ||| NNS
using  ||| S:97 E:103 ||| VBG
thyroid  ||| S:103 E:111 ||| JJ
hormones  ||| S:111 E:120 ||| NNS
The  ||| S:120 E:124 ||| DT
extent  ||| S:124 E:131 ||| NN
of  ||| S:131 E:134 ||| IN
myelination  ||| S:134 E:146 ||| NN
on  ||| S:146 E:149 ||| IN
the  ||| S:149 E:153 ||| DT
axon  ||| S:153 E:158 ||| JJ
promotes  ||| S:158 E:167 ||| JJ
transmission  ||| S:167 E:180 ||| NN
of  ||| S:180 E:183 ||| IN
impulses  ||| S:183 E:192 ||| NNS
in  ||| S:192 E:195 ||| IN
the  ||| S:195 E:199 ||| DT
neural  ||| S:199 E:206 ||| JJ
network ||| S:206 E:213 ||| NN
,  ||| S:213 E:215 ||| ,
any  ||| S:215 E:219 ||| DT
disturbances  ||| S:219 E:232 ||| NN
in  ||| S:232 E:235 ||| IN
this  ||| S:235 E:240 ||| DT
process  ||| S:240 E:248 ||| NN
results  ||| S:248 E:256 ||| NNS
in  ||| S:256 E:259 ||| IN
the  ||| S:259 E:263 ||| DT
neurodegenerative  ||| S:263 E:281 ||| JJ
condition ||| S:281 E:290 ||| NN
.  ||| S:290 E:292 ||| .
Transplantation  ||| S:292 E:308 ||| NN
of  ||| S:308 E:311 ||| IN
oligodendrocyte  ||| S:311 E:327 ||| JJ
precursors  ||| S:327 E:338 ||| NN
that  ||| S:338 E:343 ||| WDT
supports  ||| S:343 E:352 ||| VBZ
in  ||| S:352 E:355 ||| IN
the  ||| S:355 E:359 ||| DT
regeneration  ||| S:359 E:372 ||| NN
of  ||| S:372 E:375 ||| IN
axons  ||| S:375 E:381 ||| NN
through  ||| S:381 E:389 ||| IN
myelination  ||| S:389 E:401 ||| NN
is  ||| S:401 E:404 ||| VBZ
an  ||| S:404 E:407 ||| DT
important  ||| S:407 E:417 ||| JJ
step  ||| S:417 E:422 ||| NN
in  ||| S:422 E:425 ||| IN
the  ||| S:425 E:429 ||| DT
restoration  ||| S:429 E:441 ||| NN
of  ||| S:441 E:444 ||| IN
damaged  ||| S:444 E:452 ||| JJ
neurons ||| S:452 E:459 ||| NN
.  ||| S:459 E:461 ||| .
Therefore ||| S:461 E:470 ||| RB
,  ||| S:470 E:472 ||| ,
in  ||| S:472 E:475 ||| IN
the  ||| S:475 E:479 ||| DT
present  ||| S:479 E:487 ||| JJ
study ||| S:487 E:492 ||| NN
,  ||| S:492 E:494 ||| ,
the  ||| S:494 E:498 ||| DT
differentiation  ||| S:498 E:514 ||| NN
of  ||| S:514 E:517 ||| IN
human  ||| S:517 E:523 ||| JJ
CD34+  ||| S:523 E:529 ||| CD
stem  ||| S:529 E:534 ||| NN
cells  ||| S:534 E:540 ||| NNS
into  ||| S:540 E:545 ||| IN
oligodendrocytes  ||| S:545 E:562 ||| NN
was  ||| S:562 E:566 ||| VBD
carried  ||| S:566 E:574 ||| VBN
out ||| S:574 E:577 ||| RP
.  ||| S:577 E:579 ||| .
The  ||| S:579 E:583 ||| DT
pure  ||| S:583 E:588 ||| JJ
human  ||| S:588 E:594 ||| JJ
CD34+  ||| S:594 E:600 ||| CD
culture  ||| S:600 E:608 ||| NN
developed  ||| S:608 E:618 ||| VBN
from  ||| S:618 E:623 ||| IN
the  ||| S:623 E:627 ||| DT
stem  ||| S:627 E:632 ||| NN
cells  ||| S:632 E:638 ||| NNS
obtained  ||| S:638 E:647 ||| VBN
from  ||| S:647 E:652 ||| IN
a  ||| S:652 E:654 ||| DT
peripheral  ||| S:654 E:665 ||| JJ
blood  ||| S:665 E:671 ||| NN
of  ||| S:671 E:674 ||| IN
a  ||| S:674 E:676 ||| DT
donor  ||| S:676 E:682 ||| NN
were  ||| S:682 E:687 ||| VBD
subjected  ||| S:687 E:697 ||| VBN
to  ||| S:697 E:700 ||| TO
oligodendrocyte  ||| S:700 E:716 ||| VB
differentiation  ||| S:716 E:732 ||| JJ
medium  ||| S:732 E:739 ||| NN
( ||| S:739 E:740 ||| -LRB-
ODM ||| S:740 E:743 ||| NNP
) ||| S:743 E:744 ||| -RRB-
.  ||| S:744 E:746 ||| .
The  ||| S:746 E:750 ||| DT
ODM  ||| S:750 E:754 ||| NNP
at  ||| S:754 E:757 ||| IN
a  ||| S:757 E:759 ||| DT
concentration  ||| S:759 E:773 ||| NN
of  ||| S:773 E:776 ||| IN
40ng ||| S:776 E:780 ||| CD
/ ||| S:780 E:781 ||| CD
ml  ||| S:781 E:784 ||| JJ
thyroxine ||| S:784 E:793 ||| NN
,  ||| S:793 E:795 ||| ,
40ng ||| S:795 E:799 ||| FW
/ ||| S:799 E:800 ||| FW
ml  ||| S:800 E:803 ||| FW
3,3 ||| S:803 E:806 ||| NNP
' ||| S:806 E:807 ||| POS
, ||| S:807 E:808 ||| ,
5-tri-iodo-thyronine  ||| S:808 E:829 ||| NNP
showed  ||| S:829 E:836 ||| VBD
distinct  ||| S:836 E:845 ||| JJ
morphological  ||| S:845 E:859 ||| JJ
changes  ||| S:859 E:867 ||| NNS
from  ||| S:867 E:872 ||| IN
day  ||| S:872 E:876 ||| NN
6  ||| S:876 E:878 ||| CD
to  ||| S:878 E:881 ||| TO
9  ||| S:881 E:883 ||| CD
with  ||| S:883 E:888 ||| IN
cells  ||| S:888 E:894 ||| NNS
exhibiting  ||| S:894 E:905 ||| VBG
conspicuous  ||| S:905 E:917 ||| JJ
stellate  ||| S:917 E:926 ||| JJ
morphology  ||| S:926 E:937 ||| NN
and  ||| S:937 E:941 ||| CC
extensive  ||| S:941 E:951 ||| JJ
foot  ||| S:951 E:956 ||| NN
processes ||| S:956 E:965 ||| NNS
.  ||| S:965 E:967 ||| .
The  ||| S:967 E:971 ||| DT
real-time  ||| S:971 E:981 ||| JJ
PCR  ||| S:981 E:985 ||| NNP
analysis  ||| S:985 E:994 ||| NN
showed  ||| S:994 E:1001 ||| VBD
prominent  ||| S:1001 E:1011 ||| JJ
expression  ||| S:1011 E:1022 ||| NN
of  ||| S:1022 E:1025 ||| IN
Olig2 ||| S:1025 E:1030 ||| NNP
,  ||| S:1030 E:1032 ||| ,
CNPase ||| S:1032 E:1038 ||| NNP
,  ||| S:1038 E:1040 ||| ,
PDGFRÎ±  ||| S:1040 E:1047 ||| JJ
and  ||| S:1047 E:1051 ||| CC
PLP1 ||| S:1051 E:1055 ||| CD
/ ||| S:1055 E:1056 ||| CD
DM20  ||| S:1056 E:1061 ||| CD
in  ||| S:1061 E:1064 ||| IN
the  ||| S:1064 E:1068 ||| DT
differentiated  ||| S:1068 E:1083 ||| JJ
cells  ||| S:1083 E:1089 ||| NNS
confirming  ||| S:1089 E:1100 ||| VBG
the  ||| S:1100 E:1104 ||| DT
formed  ||| S:1104 E:1111 ||| JJ
cells  ||| S:1111 E:1117 ||| NNS
are  ||| S:1117 E:1121 ||| VBP
oligodendrocyte  ||| S:1121 E:1137 ||| JJ
precursors ||| S:1137 E:1147 ||| NN
.  ||| S:1147 E:1149 ||| .
The  ||| S:1149 E:1153 ||| DT
expression  ||| S:1153 E:1164 ||| NN
of  ||| S:1164 E:1167 ||| IN
these  ||| S:1167 E:1173 ||| DT
genes  ||| S:1173 E:1179 ||| NNS
increased  ||| S:1179 E:1189 ||| VBN
from  ||| S:1189 E:1194 ||| IN
days  ||| S:1194 E:1199 ||| NNS
6  ||| S:1199 E:1201 ||| CD
to  ||| S:1201 E:1204 ||| TO
9  ||| S:1204 E:1206 ||| CD
corresponding  ||| S:1206 E:1220 ||| JJ
to  ||| S:1220 E:1223 ||| TO
the  ||| S:1223 E:1227 ||| DT
morphological  ||| S:1227 E:1241 ||| JJ
changes  ||| S:1241 E:1249 ||| NNS
observed  ||| S:1249 E:1258 ||| VBD
with  ||| S:1258 E:1263 ||| IN
almost  ||| S:1263 E:1270 ||| RB
no  ||| S:1270 E:1273 ||| DT
expression  ||| S:1273 E:1284 ||| NN
of  ||| S:1284 E:1287 ||| IN
GFAP+  ||| S:1287 E:1293 ||| CD
cells ||| S:1293 E:1298 ||| NNS
.  ||| S:1298 E:1300 ||| .
The  ||| S:1300 E:1304 ||| DT
distinct  ||| S:1304 E:1313 ||| JJ
CNPase  ||| S:1313 E:1320 ||| JJ
activity  ||| S:1320 E:1329 ||| NN
was  ||| S:1329 E:1333 ||| VBD
observed  ||| S:1333 E:1342 ||| VBN
in  ||| S:1342 E:1345 ||| IN
these  ||| S:1345 E:1351 ||| DT
differentiated  ||| S:1351 E:1366 ||| JJ
cells  ||| S:1366 E:1372 ||| NNS
compared  ||| S:1372 E:1381 ||| VBN
to  ||| S:1381 E:1384 ||| TO
normal  ||| S:1384 E:1391 ||| JJ
CD34+  ||| S:1391 E:1397 ||| CD
stem  ||| S:1397 E:1402 ||| NN
cells  ||| S:1402 E:1408 ||| NNS
correlating  ||| S:1408 E:1420 ||| VBN
with  ||| S:1420 E:1425 ||| IN
results  ||| S:1425 E:1433 ||| NNS
of  ||| S:1433 E:1436 ||| IN
real-time  ||| S:1436 E:1446 ||| JJ
PCR  ||| S:1446 E:1450 ||| NNP
conclusively  ||| S:1450 E:1463 ||| NN
explains  ||| S:1463 E:1472 ||| VBZ
the  ||| S:1472 E:1476 ||| DT
development  ||| S:1476 E:1488 ||| NN
of  ||| S:1488 E:1491 ||| IN
oligodendrocytes  ||| S:1491 E:1508 ||| NN
from  ||| S:1508 E:1513 ||| IN
human  ||| S:1513 E:1519 ||| JJ
CD34+  ||| S:1519 E:1525 ||| CD
stem  ||| S:1525 E:1530 ||| NN
cells ||| S:1530 E:1535 ||| NNS
.  ||| S:1535 E:1537 ||| .
